TY - JOUR
T1 - A RUNX2 stabilization pathway mediates physiologic and pathologic bone formation
AU - Kim, Jung Min
AU - Yang, Yeon Suk
AU - Park, Kwang Hwan
AU - Ge, Xianpeng
AU - Xu, Ren
AU - Li, Na
AU - Song, Minkyung
AU - Chun, Hyunho
AU - Bok, Seoyeon
AU - Charles, Julia F.
AU - Filhol-Cochet, Odile
AU - Boldyreff, Brigitte
AU - Dinter, Teresa
AU - Yu, Paul B.
AU - Kon, Ning
AU - Gu, Wei
AU - Takarada, Takeshi
AU - Greenblatt, Matthew B.
AU - Shim, Jae Hyuck
N1 - Funding Information:
We would like to thank Drs Renny Francheschi, Laurie Glimcher, Sarah Bettigole, and Ellen Gravallese for helpful discussion and Drs Douglas Ballon and Bin He of the Citigroup Biomedical Imaging Core of Weill Cornell Medicine for assistance with microCT imaging. We also thank the many individuals who provided valuable reagents. This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014R1A6A3A03055719, J.M.K.). M.B.G. holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund, a Basil O’Connor Award from the March of Dimes and is supported by an NIH Director’s Early Independence Award (1DP5OD021351), and a Pershing Square Sohn Cancer Research Prize for Young Investigators. J.H.S holds support from NIAMS of the NIH under R01AR068983, R21AR072836, and R21AR073331, an UMCCTS pilot project program award.
Publisher Copyright:
© 2020, The Author(s).
PY - 2020/12/1
Y1 - 2020/12/1
N2 - The osteoblast differentiation capacity of skeletal stem cells (SSCs) must be tightly regulated, as inadequate bone formation results in low bone mass and skeletal fragility, and over-exuberant osteogenesis results in heterotopic ossification (HO) of soft tissues. RUNX2 is essential for tuning this balance, but the mechanisms of posttranslational control of RUNX2 remain to be fully elucidated. Here, we identify that a CK2/HAUSP pathway is a key regulator of RUNX2 stability, as Casein kinase 2 (CK2) phosphorylates RUNX2, recruiting the deubiquitinase herpesvirus-associated ubiquitin-specific protease (HAUSP), which stabilizes RUNX2 by diverting it away from ubiquitin-dependent proteasomal degradation. This pathway is important for both the commitment of SSCs to osteoprogenitors and their subsequent maturation. This CK2/HAUSP/RUNX2 pathway is also necessary for HO, as its inhibition blocked HO in multiple models. Collectively, active deubiquitination of RUNX2 is required for bone formation and this CK2/HAUSP deubiquitination pathway offers therapeutic opportunities for disorders of inappropriate mineralization.
AB - The osteoblast differentiation capacity of skeletal stem cells (SSCs) must be tightly regulated, as inadequate bone formation results in low bone mass and skeletal fragility, and over-exuberant osteogenesis results in heterotopic ossification (HO) of soft tissues. RUNX2 is essential for tuning this balance, but the mechanisms of posttranslational control of RUNX2 remain to be fully elucidated. Here, we identify that a CK2/HAUSP pathway is a key regulator of RUNX2 stability, as Casein kinase 2 (CK2) phosphorylates RUNX2, recruiting the deubiquitinase herpesvirus-associated ubiquitin-specific protease (HAUSP), which stabilizes RUNX2 by diverting it away from ubiquitin-dependent proteasomal degradation. This pathway is important for both the commitment of SSCs to osteoprogenitors and their subsequent maturation. This CK2/HAUSP/RUNX2 pathway is also necessary for HO, as its inhibition blocked HO in multiple models. Collectively, active deubiquitination of RUNX2 is required for bone formation and this CK2/HAUSP deubiquitination pathway offers therapeutic opportunities for disorders of inappropriate mineralization.
UR - http://www.scopus.com/inward/record.url?scp=85084253496&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084253496&partnerID=8YFLogxK
U2 - 10.1038/s41467-020-16038-6
DO - 10.1038/s41467-020-16038-6
M3 - Article
C2 - 32385263
AN - SCOPUS:85084253496
SN - 2041-1723
VL - 11
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 2289
ER -